| __timestamp | Gilead Sciences, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 2983000000 | 381287000 |
| Thursday, January 1, 2015 | 3426000000 | 452612000 |
| Friday, January 1, 2016 | 3398000000 | 316800000 |
| Sunday, January 1, 2017 | 3878000000 | 330100000 |
| Monday, January 1, 2018 | 4056000000 | 265800000 |
| Tuesday, January 1, 2019 | 4381000000 | 336200000 |
| Wednesday, January 1, 2020 | 5151000000 | 423900000 |
| Friday, January 1, 2021 | 5246000000 | 467000000 |
| Saturday, January 1, 2022 | 5673000000 | 487000000 |
| Sunday, January 1, 2023 | 6090000000 | 477100000 |
| Monday, January 1, 2024 | 6091000000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, Gilead Sciences, Inc. and United Therapeutics Corporation have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Gilead Sciences has seen a steady increase in SG&A expenses, growing by approximately 104%, reflecting its aggressive expansion and marketing strategies. In contrast, United Therapeutics has maintained a more conservative growth, with a 25% increase over the same period, indicating a more stable approach to operational costs.
These trends highlight the strategic differences in managing operational costs between these two industry leaders.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or United Therapeutics Corporation
Operational Costs Compared: SG&A Analysis of AstraZeneca PLC and United Therapeutics Corporation
Selling, General, and Administrative Costs: Gilead Sciences, Inc. vs Neurocrine Biosciences, Inc.
Who Optimizes SG&A Costs Better? Gilead Sciences, Inc. or Intra-Cellular Therapies, Inc.
Breaking Down SG&A Expenses: Gilead Sciences, Inc. vs Axsome Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Gilead Sciences, Inc. and Opthea Limited
Selling, General, and Administrative Costs: Gilead Sciences, Inc. vs Xenon Pharmaceuticals Inc.
Teva Pharmaceutical Industries Limited and United Therapeutics Corporation: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: United Therapeutics Corporation vs Summit Therapeutics Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Ascendis Pharma A/S
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Perrigo Company plc
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Celldex Therapeutics, Inc.